Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jean-Francois Baron"'
Autor:
Wolfgang Buhre, Dianne de Korte-de Boer, Marcelo Gama de Abreu, Thomas Scheeren, Matthias Gruenewald, Andreas Hoeft, Donat R. Spahn, Alexander Zarbock, Sylvia Daamen, Martin Westphal, Ute Brauer, Tamara Dehnhardt, Sonja Schmier, Jean-Francois Baron, Stefan De Hert, Željka Gavranović, Bernard Cholley, Tomas Vymazal, Wojciech Szczeklik, Helmar Bornemann-Cimenti, Marina Blanca Soro Domingo, Ioana Grintescu, Radmilo Jankovic, Javier Belda
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Hydroxyethyl starch (HES) solutions are used for volume therapy to treat hypovolemia due to acute blood loss and to maintain hemodynamic stability. This study was requested by the European Medicines Agency (EMA) to provide more ev
Externí odkaz:
https://doaj.org/article/b3d37ae1d6f9415c95bbaad27df4344d
Autor:
Jean-Francois Baron, Massimiliano Povero, Lorenzo Pradelli, Astrid Feuersenger, Hartmut Bürkle, Giorgio Della-Rocca, Martin Westphal, Tim-Gerald Kampmeier
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Lorenzo Pradelli,1 Massimiliano Povero,1 Hartmut Bürkle,2 Tim-Gerald Kampmeier,3 Giorgio Della-Rocca,4 Astrid Feuersenger,5 Jean-Francois Baron,6 Martin Westphal5 1AdRes HE&OR, Torino, Italy; 2Department of Anaesthesiology and Critical Care Medicine
Autor:
Jean-Francois Baron, Johannes Treib
Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively o
Autor:
Arrnelle Nicolas-Robin, Serge Delayance, Nicola D'Attellis, Alain Carpentier, Jean Francois Baron
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 11:467-473
Objective: In the current study, the use of a target-controlled infusion of low-dose propofol was combined with a continuous infusion of sufentanil for patients undergoing mitral valve surgery. The purpose of the study was to evaluate the hemodynamic
Autor:
Jean-Francois, Baron, Eric, Vicaut, Olivier, Stucker, Marie-Christine, Villereal, Claude, Ropars, Bernard, Teisseire, Michel, Duvelleroy
Publikováno v:
Artificial Cells, Blood Substitutes, and Biotechnology; 1988, Vol. 16 Issue: 5 p871-885, 15p
Publikováno v:
Národní knihovna České republiky.
Autor:
Xavier Forceville, François Philippart, Julien Maizel, Alexandra Heininger, Thierry Boulain, Marc Feissel, Hugo Van Aken, Bertrand Guidet, Michel Hasselmann, Jean François Poussel, Olivier Martinet
Publikováno v:
Critical Care
Critical Care, BioMed Central, 2012, 16 (3), pp.R94. 〈10.1186/cc11358〉
Critical Care, BioMed Central, 2012, 16 (3), pp.R94. ⟨10.1186/cc11358⟩
Critical Care, 2012, 16 (3), pp.R94. ⟨10.1186/cc11358⟩
Critical Care, BioMed Central, 2012, 16 (3), pp.R94. 〈10.1186/cc11358〉
Critical Care, BioMed Central, 2012, 16 (3), pp.R94. ⟨10.1186/cc11358⟩
Critical Care, 2012, 16 (3), pp.R94. ⟨10.1186/cc11358⟩
International audience; ABSTRACT: INTRODUCTION: Inadequate initial treatment and delayed hemodynamic stabilization (HDS) may be associated with increased risk of death in severe sepsis patients. METHODS: in order to compare the hemodynamic efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd41acc886cf647827e07779d8117aca
http://www.hal.inserm.fr/inserm-00706029/file/cc11358.pdf
http://www.hal.inserm.fr/inserm-00706029/file/cc11358.pdf